VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ASTHAstrana Health, Inc.
$39.59$2.0B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksASTHEarnings History

ASTH logoAstrana Health, Inc. (ASTH) Earnings History

Earnings Pressure

11 years of earnings data (2015–2025) · 5-year EPS trend is negative

TTM Net Income
$30M
● Profitable
TTM EPS (Diluted)
$0.62
Per share, diluted
YoY EPS Growth
-48.9%
Declining
Net Margin
0.7%
After-tax profitability
EPS Growth Rate (CAGR)
1Y-48.9%
3Y-22.5%
5Y-14.6%
10YN/A
Operating Margin2.5%
Gross Margin9.3%
Return on Equity4.2%
Return on Assets1.3%
Record Annual Net Income$69MFY2021
Record Quarterly EPS$0.74Q3 2021
Consecutive Profitable Years5years
Q1 2026
Net Income$14M
EPS (Diluted)$0.29
YoY Growth-48.9%Declining
QoQ Growth+140.6%Excellent

Loading earnings history...

Astrana Health, Inc. (ASTH) Earnings Overview

As of June 23, 2026, Astrana Health, Inc. (ASTH) reported trailing twelve-month net income of $30M, reflecting -48.9% year-over-year growth. The company earned $0.62 per diluted share over the past four quarters, with a net profit margin of 0.7%.

Looking at the long-term picture, ASTH's 5-year EPS compound annual growth rate (CAGR) stands at -14.6%, signaling declining earnings. The company achieved its highest annual net income of $69M in fiscal 2021.

Astrana Health, Inc. maintains positive profitability with a gross margin of 9.3%, operating margin of 2.5%, and net margin of 0.7%. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including ALHC ($20M net income, -0.0% margin), CLOV (-$57M net income, -4.4% margin), OSCR (-$39M net income, -3.8% margin), ASTH has outperformed on profitability metrics. Compare ASTH vs ALHC →

ASTH Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
ASTH logoASTHCurrent
$30M$0.620.7%4.2%-48.9%—
ALHC logoALHC
$20M$0.09-0.0%-0.5%+99.4%
CLOV logoCLOV
-$57M$-0.11-4.4%-26.3%-93.6%
OSCR logoOSCR
-$39M$-0.12-3.8%-44.4%-1865.9%
WELL logoWELL
$1.4B$1.978.8%2.5%-11.5%
AGL logoAGL
-$373M$-22.42-6.8%-135.6%-55.6%
Best in group
Lowest in group

ASTH Historical Earnings Data (2015–2025)

10 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$22M-47.9%$79M$0.460.7%2.5%
2024$43M-28.9%$89M$0.902.1%4.4%
2023$61M+34.4%$85M$1.294.4%6.1%
2022$45M-34.5%$104M$0.993.9%9.1%
2021$69M+390.2%$98M$1.528.9%12.7%
2020-$24M-268.3%$6M$1.01-6.4%1.6%
2019$14M+30.3%$32M$0.392.5%5.8%
2018$11M-58.0%$92M$0.292.1%17.7%
2017$26M+376.1%$38M$0.907.2%10.5%
2015-$9M--$7M$-1.79-21.2%-14.9%

Download Data

Export ASTH earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

11+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ASTH — Frequently Asked Questions

Quick answers to the most common questions about buying ASTH stock.

What is ASTH earnings per share (EPS)?

ASTH trailing twelve-month (TTM) diluted EPS is $0.62, reflecting -48.9% year-over-year growth. The 5-year EPS CAGR is -14.6%. Complete EPS history from 2015 to 2025 is available in the table on this page.

What is Astrana Health, Inc.'s net income?

Astrana Health, Inc. (ASTH) trailing twelve-month net income is $30M as of 2025. Earnings declined -48.9% year-over-year. Astrana Health, Inc. has been profitable for 5 consecutive years.

Is ASTH profitable?

Yes, ASTH is profitable with a TTM net income of $30M and a net profit margin of +0.7%. Astrana Health, Inc. has generated profits for 5 consecutive years.

What is ASTH's earnings growth rate?

ASTH compound annual EPS growth rates (CAGR): 1-Year: -48.9%, 3-Year: -22.5%, 5-Year: -14.6%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2015 to 2025.

What are ASTH's profit margins?

Astrana Health, Inc. net profit margin is +0.7%, operating margin is +2.5%, and gross margin is +9.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is +4.2%.

Is ASTH growing earnings?

ASTH earnings are declining — EPS fell -48.9% year-over-year. TTM net income dropped to $30M. This contrasts with the 5-year CAGR of -14.6%.

What was ASTH's best earnings year?

Astrana Health, Inc.'s highest annual net income on record is $69M, achieved in fiscal year 2021. Earnings history on this page spans 2015 to 2025 and includes all annual and quarterly figures.

What were ASTH's earnings last quarter?

ASTH's most recent reported quarter was Q1 2026. Net income was $14M with diluted EPS of $0.29. For a full breakdown of all quarters, see the quarterly earnings table on this page.

ASTH Earnings Over Time (2015–2025)

Net income & EPS — annual and quarterly view